PREPL in Health and Disease
NCT02263781 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 125
Last updated 2024-07-16
Summary
Evaluation of PREPL activity in healthy controls and known or possible PREPL deficient patients
Conditions
- Hypotonia-Cystinuria Syndrome
- Muscle Hypotonia
- Healthy Volunteers
- Dwarfism, Growth Hormone Deficiency
- Obesity
- Prader-Willi Syndrome
Interventions
- PROCEDURE
-
Blood draw
Blood draw
- PROCEDURE
-
muscle biopsy
Muscle biopsy during planned anesthesia/surgery
Sponsors & Collaborators
-
KU Leuven
collaborator OTHER -
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Luc Régal, MD · KU Leuven
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2025-01-31
- Completion
- 2025-01-31
Countries
- Belgium
Study Locations
More Related Trials
-
Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge
NCT05418049 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Nutrition Status of Adults Treated With Pegvaliase
NCT03792451 ·Status: COMPLETED
-
Retrospective and Prospective Observational Study of MRI Changes in Bone and Visceral Lesions of Patients With Type 1 Gaucher Disease Treated With VPRIV® (Velaglucerase Alfa)
NCT03333447 ·Status: COMPLETED
-
Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
NCT03856203 ·Status: COMPLETED
-
A Safety Study of NNZ-2566 in Patients With Rett Syndrome
NCT01703533 ·Status: COMPLETED ·Phase: PHASE2
-
Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008
NCT04995315 ·Status: COMPLETED
-
Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia
NCT06560346 ·Status: WITHDRAWN
-
Identification of Undiagnosed Gaucher Disease
NCT01716741 ·Status: UNKNOWN ·Phase: NA
-
Comprehensive Assessment of Reactions to Pharmacogenetics in Complex Care Patients
NCT07060300 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children
NCT01938014 ·Status: COMPLETED
-
Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome
NCT02968953 ·Status: NO_LONGER_AVAILABLE
-
Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)
NCT05200104 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.
NCT07266324 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency
NCT04007562 ·Status: WITHDRAWN
-
A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
NCT05153434 ·Status: COMPLETED ·Phase: PHASE2
-
Phenylketonuria and Hyperphenylalaninemia Nutrition Study
NCT01879995 ·Status: COMPLETED
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
Neurophysiological and Acute Pharmacological Studies in FXS Patients
NCT02998151 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
NCT00735553 ·Status: TERMINATED ·Phase: PHASE3
-
Nutritional Status in Phenylketonuria
NCT03820804 ·Status: COMPLETED
-
The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease
NCT02528617 ·Status: WITHDRAWN ·Phase: PHASE4
-
Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency
NCT04372446 ·Status: COMPLETED
-
Natural History Study of Serious Medical Events in PWS
NCT03718416 ·Status: COMPLETED
-
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
NCT01894958 ·Status: COMPLETED ·Phase: PHASE2